Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography.
Current and emerging treatment of multiple sclerosis.
Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's disease.
Postreading Self-Assessment and CME Test-Preferred Responses.
When to Suspect and How to Diagnose Mitochondrial Disorders?
The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity.
The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?
Neuropathology Associated With Diffuse Excessive High Signal Intensity Abnormalities on Magnetic Resonance Imaging in Very Preterm Infants.
Suspected Acoustic Neuroma Demyelinating Lesions.
[Immunity impact of pregnancy on the experience of the Obstetrics and Gynecology Department of Moulay Ismail Military Hospital].
Neurological Nuance: Hodgkin Lymphoma Presenting With Guillain-Barré Syndrome.
Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorates Long-Term Cognitive Impairments Caused by Neonatal Hypoxia-Ischemia in Rats.
Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines.
Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.
[Relationship between serum erythropoietin levels and brain injury in preterm infants].
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells.
The role of sleep on cognition and functional connectivity in patients with multiple sclerosis.
Meeting the mental health needs of people with multiple sclerosis: a qualitative study of patients and professionals.
Mass Spectrometry-Based Quantitative Strategies for Assessing the Biological Consequences and Repair of DNA Adducts.
Biopathology of astrocytes in human traumatic and complicated brain injuries. Review and hypothesis.
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
Is it worth to report the presence of a single and additional band in the cerebrospinal fluid detected by isoelectrofocusing?
Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.
Regarding the past, what is the trial you have always been dreaming of in CIDP?
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?

Pages